A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects

NCT02037282 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Influenza
Flu

Interventions

DRUG: Anti-influenza IVIG

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)